Fabrice Plasson
Président chez Amoeba US Corp.
Postes actifs de Fabrice Plasson
Sociétés | Poste | Début | Fin |
---|---|---|---|
Amoeba US Corp. | Président | - | - |
Entreprise Amoeba Canada, Inc. | Président | - | - |
Historique de carrière de Fabrice Plasson
Anciens postes connus de Fabrice Plasson
Sociétés | Poste | Début | Fin |
---|---|---|---|
AMOÉBA | Directeur/Membre du Conseil | - | - |
Directeur Général | 21/07/2010 | 14/12/2023 | |
Président | - | 14/12/2023 | |
Fondateur | 21/07/2010 | 14/12/2023 | |
President | 21/07/2010 | - | |
EUROFINS DISCOVERX PRODUCTS FRANCE
EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Directeur Général | - | - |
Fondateur | - | - | |
Whatman Ltd. | Corporate Officer/Principal | - | - |
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Directeur/Membre du Conseil | - | - |
Fondateur | - | - | |
Corporate Officer/Principal | - | - |
Formation de Fabrice Plasson
EM Lyon Business School | Masters Business Admin |
Université Joseph Fourier | Graduate Degree |
Statistiques
Internationale
France | 6 |
Etats-Unis | 3 |
Canada | 2 |
Opérationnelle
Chairman | 3 |
Founder | 3 |
Director/Board Member | 2 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMOÉBA | Consumer Non-Durables |
Entreprise privées | 5 |
---|---|
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Health Technology |
Whatman Ltd. | |
Amoeba US Corp. | |
Entreprise Amoeba Canada, Inc. | |
EUROFINS DISCOVERX PRODUCTS FRANCE
EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Commercial Services |
- Bourse
- Insiders
- Fabrice Plasson
- Expérience